Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 563951, 9 pages
http://dx.doi.org/10.1155/2015/563951
Research Article

Chemerin15-Ameliorated Cardiac Ischemia-Reperfusion Injury Is Associated with the Induction of Alternatively Activated Macrophages

1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China
2Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
3Department of Cardiology, Handan First Hospital, Handan 056002, China

Received 20 April 2015; Revised 29 May 2015; Accepted 1 June 2015

Academic Editor: Ronald Gladue

Copyright © 2015 Chao Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. G. Frangogiannis, C. W. Smith, and M. L. Entman, “The inflammatory response in myocardial infarction,” Cardiovascular Research, vol. 53, no. 1, pp. 31–47, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Y. Zuidema and C. Zhang, “Ischemia/reperfusion injury: the role of immune cells,” World Journal of Cardiology, vol. 2, no. 10, pp. 325–332, 2010. View at Publisher · View at Google Scholar
  3. K. A. Kaminski, T. A. Bonda, J. Korecki, and W. J. Musial, “Oxidative stress and neutrophil activation—the two keystones of ischemia/reperfusion injury,” International Journal of Cardiology, vol. 86, no. 1, pp. 41–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1121–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Steffens, F. Montecucco, and F. Mach, “The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury,” Thrombosis and Haemostasis, vol. 102, no. 2, pp. 240–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Lambert, E. F. Lopez, and M. L. Lindsey, “Macrophage roles following myocardial infarction,” International Journal of Cardiology, vol. 130, no. 2, pp. 147–158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Formigli, L. I. Manneschi, C. Nediani et al., “Are macrophages involved in early myocardial reperfusion injury?” Annals of Thoracic Surgery, vol. 71, no. 5, pp. 1596–1602, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Nahrendorf and F. K. Swirski, “Monocyte and macrophage heterogeneity in the heart,” Circulation Research, vol. 112, no. 12, pp. 1624–1633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Mantovani, A. Sica, and M. Locati, “Macrophage polarization comes of age,” Immunity, vol. 23, no. 4, pp. 344–346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Cassetta, E. Cassol, and G. Poli, “Macrophage polarization in health and disease,” TheScientificWorldJOURNAL, vol. 11, pp. 2391–2402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Gordon and F. O. Martinez, “Alternative activation of macrophages: mechanism and functions,” Immunity, vol. 32, no. 5, pp. 593–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Geissmann, S. Gordon, D. A. Hume, A. M. Mowat, and G. J. Randolph, “Unravelling mononuclear phagocyte heterogeneity,” Nature Reviews Immunology, vol. 10, no. 6, pp. 453–460, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Van Ginderachter, K. Movahedi, G. Hassanzadeh Ghassabeh et al., “Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion,” Immunobiology, vol. 211, no. 6–8, pp. 487–501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Dayan, G. Yannarelli, F. Billia et al., “Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction,” Basic Research in Cardiology, vol. 106, no. 6, pp. 1299–1310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. B. Goralski, T. C. McCarthy, E. A. Hanniman et al., “Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism,” The Journal of Biological Chemistry, vol. 282, no. 38, pp. 28175–28188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Luangsay, V. Wittamer, B. Bondue et al., “Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model,” Journal of Immunology, vol. 183, no. 10, pp. 6489–6499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Parolini, A. Santoro, E. Marcenaro et al., “The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues,” Blood, vol. 109, no. 9, pp. 3625–3632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. L. Rourke, H. J. Dranse, and C. J. Sinal, “Towards an integrative approach to understanding the role of chemerin in human health and disease,” Obesity Reviews, vol. 14, no. 3, pp. 245–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. K. L. Graham, B. A. Zabel, S. Loghavi et al., “Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease,” Journal of Immunology, vol. 183, no. 10, pp. 6717–6723, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Kukla, K. Zwirska-Korczala, A. Gabriel et al., “Chemerin, vaspin and insulin resistance in chronic hepatitis C,” Journal of Viral Hepatitis, vol. 17, no. 9, pp. 661–667, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Tomalka-Kochanowska, B. Baranowska, E. Wolinska-Witort et al., “Plasma chemerin levels in patients with multiple sclerosis,” Neuroendocrinology Letters, vol. 35, pp. 218–223, 2014. View at Google Scholar
  22. Q. Ji, Y. Lin, Z. Liang et al., “Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris,” Cardiovascular Diabetology, vol. 13, article 145, 2014. View at Publisher · View at Google Scholar
  23. X.-Y. Du and L. L. K. Leung, “Proteolytic regulatory mechanism of chemerin bioactivity,” Acta Biochimica et Biophysica Sinica, vol. 41, no. 12, pp. 973–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, and D. Communi, “Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity,” Journal of Immunology, vol. 175, no. 1, pp. 487–493, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Cash, R. Hart, A. Russ et al., “Synthetic chemerin-derived peptides suppress inflammation through ChemR23,” Journal of Experimental Medicine, vol. 205, no. 4, pp. 767–775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Cash, M. D. Bass, J. Campbell, M. Barnes, P. Kubes, and P. Martin, “Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring,” Current Biology, vol. 24, no. 12, pp. 1406–1414, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Cash, S. Bena, S. E. Headland, S. McArthur, V. Brancaleone, and M. Perretti, “Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23,” EMBO Reports, vol. 14, no. 11, pp. 999–1007, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Yan, A. Anzai, Y. Katsumata et al., “Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 62, pp. 24–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Wu, K. Meng, Q. Ji et al., “Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice,” Clinical and Experimental Immunology, vol. 176, no. 3, pp. 438–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Matsushima, J. Kuroda, T. Ago et al., “Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α,” Circulation Research, vol. 112, no. 8, pp. 1135–1149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Fliss and D. Gattinger, “Apoptosis in ischemic and reperfused rat myocardium,” Circulation Research, vol. 79, no. 5, pp. 949–956, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. B. A. Zabel, S. Nakae, L. Zúñiga et al., “Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis,” The Journal of Experimental Medicine, vol. 205, no. 10, pp. 2207–2220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. K. E. de Greef, D. K. Ysebaert, M. Ghielli et al., “Neutrophils and acute ischemia-reperfusion injury,” Journal of Nephrology, vol. 11, no. 3, pp. 110–122, 1998. View at Google Scholar · View at Scopus
  34. J. L. Cash, A. R. Christian, and D. R. Greaves, “Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner,” Journal of Immunology, vol. 184, no. 9, pp. 5315–5324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, “Macrophage activation and polarization,” Frontiers in Bioscience, vol. 13, no. 2, pp. 453–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. P. Erwig and P. M. Henson, “Immunological consequences of apoptotic cell phagocytosis,” American Journal of Pathology, vol. 171, no. 1, pp. 2–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. E. Voll, M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite, “Immunosuppressive effects of apoptotic cells,” Nature, vol. 390, no. 6658, pp. 350–351, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. M. R. Elliott and K. S. Ravichandran, “Clearance of apoptotic cells: implications in health and disease,” Journal of Cell Biology, vol. 189, no. 7, pp. 1059–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. E. Mũoz, K. Lauber, M. Schiller, A. A. Manfredi, and M. Herrmann, “The role of defective clearance of apoptotic cells in systemic autoimmunity,” Nature Reviews Rheumatology, vol. 6, no. 5, pp. 280–289, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Takemura, N. Ouchi, R. Shibata et al., “Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies,” Journal of Clinical Investigation, vol. 117, no. 2, pp. 375–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Lovren, Y. Pan, A. Quan et al., “Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages,” The American Journal of Physiology: Heart and Circulatory Physiology, vol. 299, no. 3, pp. H656–H663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Y. McWhorter, T. Wang, P. Nguyen, T. Chung, and W. F. Liu, “Modulation of macrophage phenotype by cell shape,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 43, pp. 17253–17258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Arita, F. Bianchini, J. Aliberti et al., “Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1,” Journal of Experimental Medicine, vol. 201, no. 5, pp. 713–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Arita, T. Ohira, Y. P. Sun, S. Elangovan, N. Chiang, and C. N. Serhan, “Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation,” Journal of Immunology, vol. 178, no. 6, pp. 3912–3917, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Arita, M. Yoshida, S. Hong et al., “Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 21, pp. 7671–7676, 2005. View at Publisher · View at Google Scholar · View at Scopus